Novartis Acquires 99.07 Percent of Lek Shares

Ljubljana, 21 November - Swiss pharmaceutical Novartis acquired 99.07 percent of shares in Slovenian drug maker Lek in a takeover bid running out on 18 November, Novartis's subsidiary Servipharm, which purchased the shares, said on Thursday. According to Servipharm, the bid has succeeded.

The rest of this news item is available to subscribers.
The news item consists of 3.546 characters (without spaces) or 697 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2002